California – November 14, 2026 -- Spravato's first month means eight clinic visits and at least 16 hours of supervised observation, by our calculation from the dosing schedule. A comparison from the NutraBrain clinic and Dr. David Mahjoubi sets Spravato (esketamine) against compounded generic ketamine, which NutraBrain prescribes for home use from $349 a visit.
Spravato is the S enantiomer, one of the two mirror-image molecules in ketamine. The FDA approved it in March 2019 for treatment-resistant depression alongside an oral antidepressant. In 2020 it was also approved for depression with suicidal thoughts, and in January 2025 for use on its own. Ketamine was approved in 1970 as an anesthetic. Prescribing it for depression is off label, and compounded ketamine is not FDA approved.
Spravato's FDA approval comes with a fixed clinic schedule
Spravato is a 56 mg or 84 mg nasal spray given in a certified clinic. Doses are twice a week for four weeks, then weekly, then weekly or every two weeks. You are observed for two hours after each dose and cannot drive that day. The source says the FDA's safety program requires this, and the drug carries a boxed warning for sedation, dissociation, breathing problems, misuse and suicidal thoughts and behaviors.
Compounded ketamine comes as a nasal spray, a dissolving tablet, a sublingual troche or a daily microdose lozenge, taken at home on a schedule the physician sets. NutraBrain says it ships five formats in 15 states after a video consultation. It also says there is no published research on ketamine combined with oxytocin, which it offers with the nasal spray.
Spravato's first month works out to $4,720 to $7,080 at 2019 list prices
A 2019 launch list price of roughly $590 to $885 per session (Ross EL, 2020, Psychiatric Services) times eight sessions gives $4,720 to $7,080. That is before clinic fees. Some insurers cover Spravato after prior authorization, often with a copay per visit. Compounded ketamine is rarely covered.
- Pay Per Visit: $349 a visit
- Monthly Care: $425 to start, first prescription included, then $69 a month
- Annual membership: $1,075 a year, about $90 a month
These figures are not like for like. NutraBrain's prices exclude pharmacy-billed medication after the first month, and Spravato's list price excludes clinic fees. NutraBrain says it accepts HSA and FSA cards in most cases. The release gives no current Spravato price, only the 2019 launch figure.
No head-to-head trial has compared the two drugs
In Spravato's pivotal trial of 223 adults, about 53 percent of the esketamine group were in remission at day 28, versus 31 percent on placebo (Popova V, 2019, American Journal of Psychiatry). Ketamine infusion trials reported 64 to 71 percent response within 24 hours of a single infusion. Those measure different things, so the numbers cannot be compared directly.
Both drugs are Schedule III controlled substances. Both can cause dissociation, dizziness, nausea and a temporary rise in blood pressure. Neither is suitable during pregnancy or with uncontrolled high blood pressure. Mahjoubi is not a psychiatrist, and he recommends seeing one first and keeping one involved during treatment.
NutraBrain treats patients in 15 states, including everywhere in California.